At the 3rd International Conference on Deficiency of Adenosine Deaminase 2 (DADA2), the CEO of iXensor, Dr. Carson Chen, speaks about XLab and its applications in realizing remote collaboration of developing accessible and affordable DADA2 diagnostic test with test strip developers across the globe. Dr. Carson Chen encountered the CEO…
PixoTest® is among the fastest COVID-19 antigen tests for smarter pandemic management, detecting positive SARS-CoV-2 infection cases in as short as five minutes. The PixoTest® POCT Analyzer offers prompt, accurate, and objective results through the standardized analysis of the rapid tests. PixoHealth Pass App is positioned as the digital screening tool…
TAIPEI, TAIWAN – May 18th, 2020 – iXensor Co., Ltd. (6734.TWO). On February 21st, 2020, iXensor formed the COMBAT project team to tackle the global COVID-19 pandemic challenge from the testing and digital solution perspective, aiming to aid the early detection of COVID-19 infections. Two state-of-the-art antigen-based testing solutions are…
Eveline’s unique smart features convinced the expert jury TAIPEI, TAIWAN – April 8, 2020 – Eveline, the world’s first AI-powered ovulation prediction kit, was selected as a winner of the 2020 National Parenting Product Awards (NAPPA). NAPPA is one of the longest-running awards programs in its industry in the USA….
Taiwan-Based Pioneer in Mobile Health appoints new chairman and CEO to develop and execute its global growth strategy (Dr. Peter Fitzgerald – third from the right, Dr. Carson Chen – second from the right, Dr. Alan Tsai – third from the left) The iXensor board of directors names Dr. Peter…
The latest clinical study, Mobile Health for Diagnosis – PixoTest HbA1c POCT System(1), published in the Journal of Medical and Biological Engineering (JMBE), proved that PixoTest POCT System can be the solution for the dilemma of incorporating both portability and accuracy simultaneously. The study illustrated the following benefits of the…
PixoTest Lipid Monitoring System utilizes iXensor’s patented PixoTest technology to analyze Lipid panel tests by lighting and image sensing module of the mobile device to detect the color change reaction on the biochemical test strip.The image of the test strip is captured by the front camera of the smart device…
iXensor Co., Ltd, is the leading digital mobile health company that developed the PixoTech platform to analyze colorimetric assays using smartphone cameras. iXensor announces that its PixoTest POCT Analyzer and PixoTest A1c Test Kit has received the U.S. Food and Drug Administration 510(k) clearance for clinical laboratory and Point-of-Care. “The…
iXensor is chosen to be one of the 10 startups who can join the 2019 Merck Accelerator Program. Among 595 application all over the world, iXensor stands out by its innovative PixoTech technology which turns mobile devices into in vitro diagnostic platform. Merck Accelerator Program aims to build sustainable…
iXensor is proud to announce that we are awarded as the best of anti-diseases solution provider by Taiwan Center of Disease Control (CDC). It’s our honor to be recognized as the best helper of preventing our motherland from being attacked by Dengue! iXensor utilizes PixoTest technology to turn smart devices…
